Azienda Ospedaliera Niguarda Cà Granda

Milan 20162

0 studies enrolling now · 3 studies all time

What they study most

Hepatocellular Carcinoma, Ovarian Cancer, Pancreatic Cancer

Studies at this site

• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046. — Completed
• Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy — Completed